Skip to content

Sarepta Therapeutics, Inc. SRPT Gain (loss) on disposal of assets

Discontinued — last reported Q1 '25

Gain (loss) on disposal of assets at other companies

Capricor Therapeutics logo
Capricor TherapeuticsCAPR
-$81.14K+46.1%
Arrowhead Research logo
Arrowhead ResearchARWR

Segments

By segment

See full
All Other Segments$1.71M-98.1%

Other financials

Income statement

See full
Revenue$730.8M-1.9%
Operating income-$300.4M-961%
Net income$331.0M+174%
EPS (diluted)-$4.60-1,343%

Balance sheet

See full
Cash & equivalents$464.5M+92.8%
Total debt$198.5M-3.4%
Total equity$1.5B+31.7%
Total assets$3.2B-8.3%

Cash flow

See full
Operating cash flow-$202.7M+65.3%
CapEx$2.1M-95.2%
Free cash flow-$204.8M+67.3%

Valuation

See full
Market cap$1.76B-63.1%

Profitability

See full
Operating margin-50.8%-1.6pp
Net margin4.6%+2.4pp
FCF margin-28.7%-9.2pp

Returns & leverage

See full
Return on equity-23.6%-28.5pp
Debt / equity0.1×0.0×
Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnInvestments.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s gain (loss) on disposal of assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s gain (loss) on disposal of assets?
Sarepta Therapeutics, Inc. (SRPT) reported gain (loss) on disposal of assets of -$90.73M in Q1 2025.
How has Sarepta Therapeutics, Inc.'s gain (loss) on disposal of assets changed year-over-year?
Sarepta Therapeutics, Inc.'s gain (loss) on disposal of assets decreased by 9845.2% year-over-year, from $931K to -$90.73M.
What does gain (loss) on disposal of assets mean?
Gains or losses recognized on the disposal of businesses, property, equipment, investments, or other assets at prices above or below their carrying value.